BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12001839)

  • 21. Prevention of coronary heart disease: a nonhormonal approach.
    Lewis V; Hoeger K
    Semin Reprod Med; 2005 May; 23(2):157-66. PubMed ID: 15852201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The best of epidemiology and cardiovascular prevention in 2006].
    Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of prevention on reducing the burden of cardiovascular disease.
    Kahn R; Robertson RM; Smith R; Eddy D
    Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
    Wachtel TM; Kucia AM; Greenhill JA
    Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of risk factors after coronary heart disease in European countries].
    Amouyel P; Montaye M
    Rev Epidemiol Sante Publique; 1998 Dec; 46(6):497-507. PubMed ID: 9950050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary prevention of CHD: nine ways to reduce risk.
    Havranek EP
    Am Fam Physician; 1999 Mar; 59(6):1455-63, 1466. PubMed ID: 10193589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary prevention of coronary heart disease in the elderly.
    Dornbrook-Lavender KA; Pieper JA; Roth MT
    Ann Pharmacother; 2003 Nov; 37(11):1654-63. PubMed ID: 14565805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ischemic heart disease. Its incidence and association with risk factors].
    Nordet P; Pons P; Gonźales-Prendes CM; Ferro S; Sánchez P; Dueñas A
    Przegl Lek; 1989; 46(2):261-5. PubMed ID: 2772223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.
    Vestfold Heartcare Study Group
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):429-37. PubMed ID: 14671465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Primary and secondary prevention of coronary heart disease. A position paper of the International Task Force for the Prevention of Coronary Heart Disease].
    Cullen P; Assmann G
    Dtsch Med Wochenschr; 2000 Jul; 125(28-29):881-7. PubMed ID: 10943220
    [No Abstract]   [Full Text] [Related]  

  • 35. Statin therapy in the primary and secondary prevention of coronary artery disease in patients with type 2 diabetes. A scientific review.
    Paulo S; Fernandes S; Vizinho R; Carneiro AV
    Rev Port Cardiol; 2004 Nov; 23(11):1461-82. PubMed ID: 15693698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying women at risk for coronary artery disease.
    Birchfield PC
    AAOHN J; 2003 Jan; 51(1):15-22. PubMed ID: 12596341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of major modifiable risk factors among patients with coronary artery disease--a retrospective analysis.
    Achari V; Thakur AK
    J Assoc Physicians India; 2004 Feb; 52():103-8. PubMed ID: 15656042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
    Carević V; Rumboldt M; Rumboldt Z;
    Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Physical activity in basic and primary prevention of cardiovascular disease].
    Sobieszczańska M; Kałka D; Pilecki W; Adamus J
    Pol Merkur Lekarski; 2009 Jun; 26(156):659-64. PubMed ID: 19711738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stroke prevention: management of modifiable vascular risk factors.
    Leys D; Deplanque D; Mounier-Vehier C; Mackowiak-Cordoliani MA; Lucas C; Bordet R
    J Neurol; 2002 May; 249(5):507-17. PubMed ID: 12021938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.